Simplex Trading
VOR icon

Simplex Trading’s Vor Biopharma VOR Stock Holding History

Simplex Trading’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,905
Closed -$806K – 10176
2025
Q2 		$806K Buy
+24,905
New +$220K ﹤0.01% 3004
2023
Q1 		– Sell
-295
Closed -$39K – 10227
2022
Q4 		$39K Sell
295
-95
-24% -$9.4K ﹤0.01% 6187
2022
Q3 		$31K Buy
390
+265
+212% +$26.1K ﹤0.01% 7047
2022
Q2 		$12K Buy
125
+15
+14% +$1.53K ﹤0.01% 8150
2022
Q1 		$13K Buy
+110
New +$18.7K ﹤0.01% 8682

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $149M AUM 287.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading's VOR Position: Q2 2025 in Review

Simplex Trading sold out of Vor Biopharma (VOR) in Q2 2025, closing a stake of 348 shares — an estimated $3.08K sold.

Simplex Trading first reported a position in VOR in Q3 2022 and held it in 7 quarters. The position peaked at $46K in Q4 2022. 35 funds tracked by Wall St. Rank hold VOR as of Q2 2025.

  • Simplex Trading reported no remaining Vor Biopharma position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 348 Vor Biopharma shares in Q2 2025, an estimated $3.08K.
  • Simplex Trading first reported a position in Vor Biopharma in Q3 2022 and held it in 7 quarters.
  • Simplex Trading's Vor Biopharma position peaked at $46K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.